Trends & Forecasts

After years of speculation, we reveal what Brexit really means for pharma – so far.

Experts from our previous Power Lists discuss the challenges of leadership during these trying times.

What role have small molecules played in the fight against COVID-19?

In this eBook, thought leaders from Cambrex discuss market opportunities, drug development challenges, and more.

Sitting down with Janssen's David Lee to discuss a new era in immunology R&D.

The advanced medicine field is progressing at breakneck speed, but we must move forward with the needs of the patient in mind.

A rapid review of gene therapy’s rise – and a quick glimpse into the future.

From LIMS to AI, connected technologies are becoming a strategic initiative for an increasing number of smart companies.

Looking back at Trump’s tenure, and the potential implications of the US elections for pharma and the Affordable Health Act.

Is your business prepared for Brexit? Here’s some advice from Nik Kotecha.